Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

WISDOM’S New Fight Against Malaria

01.02.2007
The WIDSOM initiative went into top gear with its latest drug discovery challenge, which finished 31 January with an average of 80,000 compounds analysed each hour on the EGEE Grid infrastructure. In total, the challenge processed over 140 million possible docking arrangements between drug compounds and target proteins of the malaria parasite.

This virtual screening challenge of the international WISDOM (World-wide In Silico Docking On Malaria) initiative between 1 October and 31 January targeted compounds that are of interest for drug discovery against neglected diseases. WISDOM uses in silico docking techniques, where researchers use computing systems to compute the probability that potential drugs will dock with a target protein.

This lets researchers rule out the vast majority of potential drugs, so that they can concentrate on the most promising compounds in laboratory tests. This speeds up the screening process and reduces the cost of new drug development to treat diseases such as malaria.

“The impact of WISDOM goes much beyond malaria,” declared Doman Kim, Director of the Bioindustry and Technology Institute at Jeonnam National University in Korea. “The method developed can be extended to all diseases and this opens exciting industrial perspectives. Until now, the search for new drugs in the academic sector was done at a relatively small scale, whereas the WISDOM approach allows a systematic inquiry of all the potentially interesting molecules.”

... more about:
»Computing »Malaria »WISDOM »compounds »docking

This challenge was the consequence of the first, very successful large scale in silico docking, which ran on the EGEE Grid in summer 2005, when WISDOM docked over 41 million compounds in just six weeks, the equivalent of 80 years work for a single PC. The WISDOM team identified some 5000 interesting compounds, from which they found three interesting families of molecules that could be effective against the malaria parasite. Laboratories at the University of Modena, CNRS in France and CNR-ITB in Italy are now carrying out more advanced studies of the molecules using molecular dynamics. Following those studies, the enzymology laboratory of the Jeonnam National University in Korea will test them in vitro.

A second computing challenge targeting Avian Flu in April and May 2006 has significantly raised the interest of the biomedical research community. Laboratories in France, Italy, Venezuela and South Africa proposed targets for the second challenge against neglected diseases.

The WISDOM endeavour would be impossible without the support from BioSolveIT, a German firm who provided more than 6000 free floating licenses for their commercial docking program FlexX. "The WISDOM programme is very interesting and BioSolveIT is happy to sponsor this work,” says Dr Christian Lemmen, CEO of BioSolveIT. “The initiative takes full advantage of the speed and accuracy of FlexX – demonstrating the potential of the virtual screening technique in the search for drugs against neglected diseases.” Due to the initial success of the data challenge, the company even decided to extend the FlexX license for several weeks which allowed studying a new target.

In addition to the computing power that the EGEE Grid provided, AuverGrid, EELA, EUChinaGRID, EUMedGRID and South East Asia Grid all provided additional resources. The Embrace and BioinfoGRID projects are contributing to the development of a virtual, in silico screening pipeline that will allow researchers to select, for any given target protein, the most active molecules out of the millions of compounds commercially available.

Over the 10 weeks of the challenge, the project used the equivalent of 420 years of computing power of a single PC. Up to 5000 computers were used simultaneously in 27 countries, generating a total of 2000GB of useful data.

Hannelore Hammerle | alfa
Further information:
http://www.eu-egee.org/press_releases

Further reports about: Computing Malaria WISDOM compounds docking

More articles from Life Sciences:

nachricht Researchers develop eco-friendly, 4-in-1 catalyst
25.04.2017 | Brown University

nachricht Transfecting cells gently – the LZH presents a GNOME prototype at the Labvolution 2017
25.04.2017 | Laser Zentrum Hannover e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

NASA's Fermi catches gamma-ray flashes from tropical storms

25.04.2017 | Physics and Astronomy

Researchers invent process to make sustainable rubber, plastics

25.04.2017 | Materials Sciences

Transfecting cells gently – the LZH presents a GNOME prototype at the Labvolution 2017

25.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>